Пошуковий запит: (<.>A=Buchynska L$<.>) |
Загальна кількість знайдених документів : 20
Представлено документи з 1 до 20
|
1. |
Polishchuk L. Z. Cytogenetical investigation of tumor cells in patients with ovarian and endometrial cancer. — 2003 // Эксперим. онкология.
|
2. |
Buchynska L. G. Expression of p53, <$E bold roman {p21 sup {WAF1 "/" CIP1}}>, <$E bold roman {p16 sup INK4a}> and Ki-67 proteins in serous ovarian tumors. — 2007 // Эксперим. онкология.
|
3. |
Buchynska L. G. Expression of the cell cycle regulators p53, <$E bold roman {p21 sup {WAF1 "/" CIP1}}> and <$E bold roman {p16 sup INK4A}> in human endometrial adenocarcinomа. — 2006 // Эксперим. онкология.
|
4. |
Buchynska L. G. Different trends of p53, MDM2 and <$E bold roman p14 sup ARF> expression patterns in endometrial adenocarcinomas versus hyperplasia. — 2007 // Эксперим. онкология.
|
5. |
Buchynska L. Immunofluorescence staining of paraffin sections: creating DAB staining like virtual digital images using CMYK color conversion. — 2008 // Онкология.
|
6. |
Iurchenko N. Expression of MDM2 and p14ARF in p53-positive endometrial carcinomas // Укр. біохім. журн.. - 2009. - 81, № 4 (спец. вип.).
|
7. |
Buchynska L. G. FOXP3 gene promoter methylation in endometrial cancer cells // Эксперим. онкология. - 2015. - 37, № 4.
|
8. |
Buchynska L. G. The study of mismatch repair in endometrial cancer patients with a family history of cancer // Эксперим. онкология. - 2015. - 37, № 4.
|
9. |
Bilyk O. O. Analysis of p53, p16INK4a, pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas // Эксперим. онкология. - 2011. - 33, № 3.
|
10. |
Bilyk O. O. The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer // Эксперим. онкология. - 2014. - 36, № 2.
|
11. |
Chekhun S. V. Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells // Эксперим. онкология. - 2014. - 36, № 3.
|
12. |
Nesina I. P. The study of chromosomal instability in patients with endometrial cancer // Эксперим. онкология. - 2014. - 36, № 3.
|
13. |
Glushchenko N. M. Risk assessment of cancer of the female reproductive system // Эксперим. онкология. - 2014. - 36, № 3.
|
14. |
Iurchenko N. P. Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer // Эксперим. онкология. - 2014. - 36, № 4.
|
15. |
Buchynska L. G. DNA damage in tumor cells and peripheral blood lymphocytes of endometrial cancer patients assessed by the comet assay // Эксперим. онкология. - 2017. - 39, № 4.
|
16. |
Buchynska L. G. Sensitivity to 4-hydroxyestradiol and DNA repair efficiency in peripheral blood lymphocytes of endometrial cancer patients // Experimental Oncology. - 2018. - 40, № 1.
|
17. |
Nesina I. P. Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma // Experimental Oncology. - 2018. - 40, № 3.
|
18. |
Yakymenko I. Oxidative and mutagenic effects of low intensity GSM 1800 MHz microwave radiation // Experimental Oncology. - 2018. - 40, № 4.
|
19. |
Buchynska L. G. Overexpression of the mitochondria ribosomal protein S18-2 in the invasive breast carcinomas // Experimental Oncology. - 2018. - 40, № 4.
|
20. |
Buchynska L. G. Assessment of HER-2/neu, c-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas // Experimental Oncology. - 2019. - 41, № 2.
|